首页> 外国专利> Compounds derived from didhidro - 4.5 - 1H - 1,2,4 triazol 5 - (oxo or Uncle) - 1,3,4 - potency of the Tri substituted Compounds, Alpha receptor agonists of the peroxisome proliferator activated (PPAR alpha), composition, Pharmaceutical,In vitro process and its use in the treatment of diabetes mellitus, cardiovascular disease, Syndrome X, and obesity, among others.

Compounds derived from didhidro - 4.5 - 1H - 1,2,4 triazol 5 - (oxo or Uncle) - 1,3,4 - potency of the Tri substituted Compounds, Alpha receptor agonists of the peroxisome proliferator activated (PPAR alpha), composition, Pharmaceutical,In vitro process and its use in the treatment of diabetes mellitus, cardiovascular disease, Syndrome X, and obesity, among others.

机译:衍生自双吡啶的化合物-4.5-1H-[1,2,4]三唑5-(氧代或叔叔)-1,3,4-三取代化合物的效力,过氧化物酶体增殖物的α受体激动剂被激活(PPAR alpha) ,组合物,药物,体外过程及其在糖尿病,心血管疾病,X综合征和肥胖症等治疗中的用途。

摘要

Compounds represented by the following Structural formula and pharmaceutically acceptable salts, solvates and hydrates of the same, where R1, R2, X, e, andW are as defined in the specification, and Pharmaceutical composition containing them, are useful in the treatment and Prevention of diabetes mellitusCardiovascular disease, Syndrome X, and obesity.
机译:由以下结构式表示的化合物及其药学上可接受的盐,溶剂化物和水合物,其中R1,R2,X,e和W如说明书中所定义,并且包含它们的药物组合物可用于治疗和预防糖尿病心血管疾病,X综合征和肥胖症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号